Table 4 |
||
|
Classification of proteins with statistically significant changes based on Gene Ontology |
||
|
Protein |
Log2 ratio year one relative to baseline |
P-value |
|
|
||
|
Blood coagulation and inflammation |
||
|
Vitronectin (VTN) |
0.374 |
9.27E-08 |
|
Ceruloplasmin (CP) [59] |
0.789 |
1.51E-06 |
|
Plasminogen (PLG) [51] |
0.307 |
1.50E-06 |
|
Kininogen (KNG1) [52] |
0.265 |
2.89E-05 |
|
Coagulation factor XII (F12) [52] |
0.364 |
4.64E-05 |
|
Coagulation factor IX (F9) |
0.558 |
8.34E-05 |
|
Coagulation factor X (F10) |
0.332 |
0.00029 |
|
Carboxypeptidase N, polypeptide 1 (CPN1) |
0.288 |
0.0002 |
|
Platelet basic protein (PPBP) |
0.273 |
0.00363 |
|
Tissue factor pathway inhibitor (TFPI) [51] |
-0.267 |
0.01152 |
|
Fibrinogen gamma chain (FGG) |
0.273 |
0.01848 |
|
Matrix metalloproteinase 2 (MMP2) |
-0.681 |
0.03019 |
|
Protein Z, vitamin K-dependent plasma glycoprotein (PROZ) |
0.676 |
0.03401 |
|
Hyaluronan-binding protein 2 (HABP2) |
0.324 |
0.00029 |
|
Metabolism |
||
|
Sex hormone binding globulin (SHBG) [68] |
1.381 |
2.30E-07 |
|
Insulin-like growth factor binding protein 1 (IGFBP1) [18] |
1.318 |
3.82E-05 |
|
Insulin-like growth factor binding protein 4 (IGFBP4) [18] |
0.773 |
8.61E-06 |
|
Apolipoprotein A-II (APOA2) [57] |
0.379 |
4.06E-06 |
|
Vitamin D binding protein (GC) [59] |
0.298 |
5.82E-06 |
|
Apolipoprotein D (APOD) [57] |
-0.396 |
0.00133 |
|
Insulin-like growth factor binding protein 6 (IGFBP6) |
0.303 |
0.00225 |
|
Insulin-like growth factor (IGF1) [18] |
-0.410 |
0.00366 |
|
Proprotein convertase subtilisin kexin 9 (PCSK9) |
0.385 |
0.02486 |
|
Serpin peptidase inhibitor, clade A, member 6 (SERPINA6) |
0.377 |
0.02446 |
|
Osteogenesis |
||
|
Fetuin B (FETUB) |
0.748 |
2.81E-07 |
|
Macrophage stimulating protein 1 (MST1) |
0.546 |
0.00154 |
|
Collagen type 1, alpha 1 (COL1A1) |
-0.494 |
0.00023 |
|
Tolloid-like protein 1, bone morphogenetic protein 1 (TLL1) |
-1.150 |
0.0467 |
|
Neurogenic locus notch homolog protein 2 (NOTCH2) |
-0.289 |
0.01946 |
|
Neurogenic locus notch homolog protein 3 (NOTCH3) |
-0.622 |
0.02133 |
|
Fetuin A (AHSG) [59] |
0.281 |
1.16E-06 |
|
Cell growth |
||
|
Inhibin, beta E (INHBE) |
0.472 |
0.01866 |
|
Follistatin-like 3 (FSTL3) |
-0.353 |
0.02042 |
|
Transforming growth factor-beta-induced protein ig-h3 (TGFBI) |
0.322 |
0.0036 |
|
Complement and immune response |
||
|
Serpin peptidase inhibitor, clade G, member 1 (SERPING1) |
0.551 |
0.01216 |
|
Complement C2 (C2) |
0.333 |
0.00215 |
|
Complement factor H-related protein 5 (CFHL5) |
0.294 |
6.72E-05 |
|
Complement factor B (BF) |
0.271 |
1.06E-06 |
|
Pantetheinase (VNN1) |
0.564 |
0.00079 |
|
Leucine-rich alpha-2-glycoprotein (LRG1) |
0.539 |
0.00031 |
|
Neutrophil defensin 1 (DEFA1) |
0.303 |
0.00683 |
|
Mannose-binding protein C (MBL2) |
-0.300 |
0.00094 |
|
TRAF-type zinc finger domain-containing protein 1 (TRAFD1) |
-3.863 |
0.00762 |
|
Lactotransferrin (LTF) [69] |
0.285 |
0.04264 |
|
Trefoil factor 3 (TFF3) |
1.936 |
0.00019 |
|
Vessel morphogenesis |
||
|
Autotaxin (ENPP2) |
0.581 |
0.00395 |
|
Vasorin (SLITL2) |
-0.383 |
0.01997 |
|
Transgelin 2 (TAGLN2) |
-0.542 |
0.01725 |
|
Endothelial differentiation G-protein coupled receptor 3 (EDG3) |
-2.998 |
0.00033 |
|
Cardiomyopathy associated protein 5 (CMYA5) |
-4.1374 |
0.01562 |
|
Other |
||
|
1.148 |
7.16E-10 |
|
|
Cathepsin S (CTSS) |
0.588 |
0.04665 |
|
Galectin-3-binding protein (LGALS3BP) |
0.416 |
0.00214 |
|
Galectin 1 (LGALS1) |
0.305 |
0.02924 |
|
E3 ubiquitin-protein ligase UBR1 (UBR1) |
-0.422 |
0.00511 |
|
Tropomyosin alpha-4 chain (TPM4) |
-1.258 |
0.0269 |
|
DNA helicase B (HELB) |
-1.862 |
0.02157 |
|
Putative Polycomb group protein ASXL1 (ASXL1) |
-2.658 |
0.02290 |
|
Protein CREG2 (CREG2) |
||
|
Protein RIC1 homolog (KIAA1432) |
-4.153 |
0.00155 |
|
Protein FAM59B (FAM59B) |
-2.755 |
0.00119 |
|
KH homology domain-containing protein 1 (C6orf148) |
-3.060 |
0.00116 |
|
Alpha-1B-glycoprotein (A1BG) |
0.331 |
1.82E-06 |
|
Disks large homolog 2 (DLG2) |
1.749 |
0.04913 |
|
|
||
|
Proteins with prior associations with ET are indicated with numbered references. |
||
|
Katayama et al. Genome Medicine 2009 1:47 doi:10.1186/gm47 |
||